Home

Sandu Pharmaceuticals Ltd PE Ratio

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

PE

35.4

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Sandu Pharmaceuticals Ltd is 35.4 as of 15 Jan 9.00 AM .
  • The P/E Ratio of Sandu Pharmaceuticals Ltd changed from 33.3 on March 2023 to 38 on March 2024 . This represents a CAGR of 6.82% over 2 years.
  • The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 53.48 as of 14 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Sandu Pharmaceuticals Ltd

No data available

Company Fundamentals for Sandu Pharmaceuticals Ltd

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

Share Price

₹ 53.48

0.88 (1.67%)

stock direction

Last updated on: Jan 14, 2025

Market Price of Sandu Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202553.48
13 Jan 202552.6
10 Jan 202554.5
09 Jan 202554.86
08 Jan 202554.98
07 Jan 202555.49
06 Jan 202555.05
03 Jan 202556.89
02 Jan 202557.21
01 Jan 202556.31

BlinkX Score for Sandu Pharmaceuticals Ltd

Asset Value vs Market Value of Sandu Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sandu Pharmaceuticals Ltd51.67
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Sandu Pharmaceuticals Ltd Explained

``

51.67

Market cap

1

Earnings

35.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sandu Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sandu Pharmaceuticals Ltd

No data available

* All values are in %

About Sandu Pharmaceuticals Ltd

  • Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
  • The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
  • This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
  • Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
  • Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

Sandu Pharmaceuticals Ltd News Hub

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he

Read more

2024-08-13 00:00:00

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12

Read more

2024-08-13 00:00:00

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a

Read more

2024-08-13 00:00:00

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024

Read more

2024-08-06 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sandu Pharmaceuticals Ltd

What is the current PE Ratio of Sandu Pharmaceuticals Ltd?

The Current PE Ratio of Sandu Pharmaceuticals Ltd is 35.42 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Sandu Pharmaceuticals Ltd last year?

The PE Ratio of Sandu Pharmaceuticals Ltd was 33.25 last year, now the PE ratio is 35.42, showing a year-on-year growth of 6.5%.

What does the PE Ratio of Sandu Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Sandu Pharmaceuticals Ltd is 35.42. This ratio indicates that investors are willing to pay 35.42 times the earnings per share for each share of Sandu Pharmaceuticals Ltd.

What is the PE Ratio Growth of Sandu Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sandu Pharmaceuticals Ltd grew by 6.5% whereas, the EPS ratio grew by 1047.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions